BREAST CANCER STAGE III

This adverse event was reported 6483 times

These drugs are most commonly taken by patients reporting BREAST CANCER STAGE III:

# Drug Count
0 LEFLUNOMIDE 1801
1 DICLOFENAC SODIUM 1764
2 RITUXIMAB 1721
3 DICLOFENAC 1715
4 METHOTREXATE SODIUM 1679
5 ADALIMUMAB 1613
6 ADALIMUMAB-ADAZ 1583
7 TOCILIZUMAB 1582
8 CETIRIZINE HYDROCHLORIDE 1573
9 ALENDRONATE SODIUM 1572
See all common drugs associated with BREAST CANCER STAGE III

BREAST CANCER STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DICLOFENAC POTASSIUM 1013 0.0916
1 GOLD 521 0.0897
2 CORTISONE ACETATE 1112 0.0890
3 PSEUDOEPHEDRINE HCL 903 0.0825
4 DESOXIMETASONE 1487 0.0771
5 NAPROXEN SODIUM 220MG 1024 0.0747
6 CHLORHEXIDINE GLUCONATE 631 0.0675
7 TOFACITINIB CITRATE 863 0.0644
8 BOTULINUM TOXIN TYPE A 795 0.0622
9 ACETAMINOPHEN AND CODEINE 731 0.0596
See all drugs enriched for association with BREAST CANCER STAGE III

BREAST CANCER STAGE III is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 153 0.0826
1 Provitamin D2 Compound [EPC] 870 0.0292
2 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 186 0.0213
3 Antirheumatic Agent [EPC] 1801 0.0170
4 Aminosalicylate [EPC] 1533 0.0152
5 beta3-Adrenergic Agonist [EPC] 657 0.0138
6 Antiseptic [EPC] 55 0.0126
7 Interleukin-6 Receptor Antagonist [EPC] 1647 0.0119
8 Histamine-1 Receptor Antagonist [EPC] 952 0.0113
9 Interleukin-12 Antagonist [EPC] 1042 0.0100
See all drug classes enriched for association with BREAST CANCER STAGE III